pre-update Archives

Blog

Maximizing Oligonucleotide Therapeutic Development: Pre-clinical and Translational Considerations

This is the second of three blog posts discussing best practices for developing oligonucleotide therapeutics.…

Certara2021 年 6 月 25 日

Article

Fundamentals of regulatory writing: the document development process

Regulatory writers lead the development of high-quality regulatory documents by working incollaboration with colleagues across…

Certara2021 年 6 月 22 日

Blog

将 Simcyp PBPK Simulator 集成到药物开发程序中的主要 10 益处

Per US FDA’s recent paper on the topic, Physiologically based Pharmacokinetic (PBPK) modeling & simulation…

Certara2021 年 6 月 22 日

Blog

Preparing for High Stakes Meetings; How to Best Convey a New Drug’s Value to Payers

This blog post includes key takeaways from the opening session of Certara’s first Strategic Evidence…

Certara2021 年 6 月 18 日

Blog

Watershed Moment for the Future of Cell Therapy Development – FDA Advisory Committee Meeting

Every FDA Advisory Committee meeting is unique, and the Cellular, Tissue, and Gene Therapies Advisory…

Certara2021 年 6 月 15 日

Brochure

推动具有影响力的科学成果从实验室走向市场

Learn how Certara drives impactful science.

Certara2021 年 6 月 14 日

On-Demand Webinar

Three Pathways have emerged in Innovative Access Agreements

The days of simply determining the market demand for a new drug as a function…

Certara2021 年 6 月 11 日

On-Demand Webinar

Outcomes Based Agreements

The days of simply determining the market demand for a new drug as a function…

Certara2021 年 6 月 11 日

Press Release

Certara Acquires UK-based Insight Medical Writing

Expands global reach and deepens regulatory expertise PRINCETON, NJ.— 2021 年 6 月 10 日– Certara, Inc., the…

Certara2021 年 6 月 10 日

Video

Your First Choice in Complex Biologics Drug Development

The pharmaceutical has made massive investments in complex biologics, a drug class that includes oligonucleotide…

Certara2021 年 6 月 1 日

pre-update

Maximizing Oligonucleotide Therapeutic Development: Pre-clinical and Translational Considerations

Fundamentals of regulatory writing: the document development process

将 Simcyp PBPK Simulator 集成到药物开发程序中的主要 10 益处

Preparing for High Stakes Meetings; How to Best Convey a New Drug’s Value to Payers

Watershed Moment for the Future of Cell Therapy Development – FDA Advisory Committee Meeting

推动具有影响力的科学成果从实验室走向市场

Three Pathways have emerged in Innovative Access Agreements

Outcomes Based Agreements

Certara Acquires UK-based Insight Medical Writing

Your First Choice in Complex Biologics Drug Development

订阅时事通讯

快捷链接

解决方案

联系我们